UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.294-295

2016

Volltextzugriff (PDF)

THU0012 BAFF Genetic Variants in Lymphomagenesis Associated with Sjogren’s Syndrome

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A168-A168

2013

Volltextzugriff (PDF)

Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome

Clinical and experimental rheumatology, 2017-07, Vol.35 (4), p.719

2017

Volltextzugriff (PDF)

Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?

Clinical and experimental rheumatology, 2018-05, Vol.36 Suppl 112 (3), p.61

2018

Volltextzugriff (PDF)

THU0028 Type i interferon signature in the peripheral blood and CXCL4 plasma levels in patients with systemic sclerosis

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.210

2017

Volltextzugriff (PDF)

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis

Journal of autoimmunity, 2015-09, Vol.63, p.47-58

2015

Volltextzugriff (PDF)

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis

Scientific reports, 2022-06, Vol.12 (1), p.9534-12, Article 9534

2022

Volltextzugriff (PDF)

CD40/CD40L signaling and its implication in health and disease

BioFactors (Oxford), 2009-11, Vol.35 (6), p.474-483

2009

Volltextzugriff (PDF)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis

Frontiers in immunology, 2020-10, Vol.11, p.582401-582401

2020

Volltextzugriff (PDF)

Expression of tissue remodelling, inflammation- and angiogenesis-related factors after eccentric exercise in humans

Molecular biology reports, 2021-05, Vol.48 (5), p.4047-4054

2021

Volltextzugriff (PDF)

Contribution of Genetic Factors to Sjögren’s Syndrome and Sjögren’s Syndrome Related Lymphomagenesis

Journal of Immunology Research, 2015-01, Vol.2015 (2015), p.1-12

2015

Volltextzugriff (PDF)

TLR7 Signaling Drives the Development of Sjögren's Syndrome

Frontiers in immunology, 2021-05, Vol.12, p.676010

2021

Volltextzugriff (PDF)

Implementation of ICH E6 (R2) through identification of data risks using analytics in oncology clinical trials

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18319-e18319

2019

Volltextzugriff (PDF)

New advances in the classification, pathogenesis and treatment of Sjogrenʼs syndrome

Current opinion in rheumatology, 2013-09, Vol.25 (5), p.623-629

2013

Volltextzugriff (PDF)

Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations

Arthritis care & research (2010), 2016-01, Vol.68 (1), p.123-131

2016

Volltextzugriff (PDF)

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2686-2696

2016

Volltextzugriff (PDF)

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes

Journal of autoimmunity, 2018-03, Vol.88, p.75-82

2018

Volltextzugriff (PDF)

Genetic contributors and soluble mediators in prediction of autoimmune comorbidity

Journal of autoimmunity, 2019-11, Vol.104, p.102317-102317, Article 102317

2019

Volltextzugriff (PDF)

Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis

Frontiers in immunology, 2023-12, Vol.14, p.1274060-1274060

2023

Volltextzugriff (PDF)

B-cell activating factor and related genetic variants in lupus related atherosclerosis

Journal of autoimmunity, 2018-08, Vol.92, p.87-92

2018

Volltextzugriff (PDF)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

Frontiers in pharmacology, 2022-08, Vol.13, p.898049-898049

2022

Volltextzugriff (PDF)

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren’s Syndrome Patients

Journal of Immunology Research, 2018-01, Vol.2018 (2018), p.1-8

2018

Volltextzugriff (PDF)

Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma

Current issues in molecular biology, 2022-10, Vol.44 (10), p.4714-4734

2022

Volltextzugriff (PDF)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?

Frontiers in immunology, 2021-06, Vol.12, p.683623-683623

2021

Volltextzugriff (PDF)

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome

Scientific reports, 2017-08, Vol.7 (1), p.7354-8, Article 7354

2017

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(85)
Spanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial

THU0012 BAFF Genetic Variants in Lymphomagenesis Associated with Sjogren’s Syndrome

Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome

Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?

THU0028 Type i interferon signature in the peripheral blood and CXCL4 plasma levels in patients with systemic sclerosis

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis

CD40/CD40L signaling and its implication in health and disease

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis

Expression of tissue remodelling, inflammation- and angiogenesis-related factors after eccentric exercise in humans

Contribution of Genetic Factors to Sjögren’s Syndrome and Sjögren’s Syndrome Related Lymphomagenesis

TLR7 Signaling Drives the Development of Sjögren's Syndrome

Implementation of ICH E6 (R2) through identification of data risks using analytics in oncology clinical trials

New advances in the classification, pathogenesis and treatment of Sjogrenʼs syndrome

Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes

Genetic contributors and soluble mediators in prediction of autoimmune comorbidity

Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis

B-cell activating factor and related genetic variants in lupus related atherosclerosis

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren’s Syndrome Patients

Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome

Suchergebnisse filtern